Literature DB >> 29170744

Murine in vivo CD8+ T Cell Killing Assay.

Myoungjoo V Kim1, Weiming Ouyang2, Will Liao3, Michael Q Zhang4, Ming O Li5.   

Abstract

Antigen-specific killing ability of effector CD8+ T cells is critical for protective immunity against infection. Here, we describe in vivo cytotoxic T cell assay to examine effector function of antigen-specific CD8+ T cells. Mice infected with Listeria monocytogenes (L. monocytogenes) expressing chicken ovalbumin as a model antigen mount ovalbumin-specific CD8+ T cell responses. Effector CD8+ T cell function in vivo is determined by mixed transfer of OVA peptide-pulsed target cells with control target cells into the previously immunized mice. Difference in CFSE expression levels clearly marks two distinct populations: Antigen-pulsed target cells-CFSElow vs. unpulsed target cells-CFSEhi. The frequencies between antigen-pulsed target cells and control target cells are used as readouts of antigen-specific killing.

Entities:  

Year:  2014        PMID: 29170744      PMCID: PMC5697738          DOI: 10.21769/BioProtoc.1172

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  2 in total

Review 1.  Tracing tolerance and immunity in vivo by CFSE-labeling of administered cells.

Authors:  Elizabeth Ingulli
Journal:  Methods Mol Biol       Date:  2007

2.  The transcription factor Foxo1 controls central-memory CD8+ T cell responses to infection.

Authors:  Myoungjoo V Kim; Weiming Ouyang; Will Liao; Michael Q Zhang; Ming O Li
Journal:  Immunity       Date:  2013-08-08       Impact factor: 31.745

  2 in total
  3 in total

1.  In vivo CRISPR screening reveals nutrient signaling processes underpinning CD8+ T cell fate decisions.

Authors:  Hongling Huang; Peipei Zhou; Jun Wei; Lingyun Long; Hao Shi; Yogesh Dhungana; Nicole M Chapman; Guotong Fu; Jordy Saravia; Jana L Raynor; Shaofeng Liu; Gustavo Palacios; Yong-Dong Wang; Chenxi Qian; Jiyang Yu; Hongbo Chi
Journal:  Cell       Date:  2021-02-25       Impact factor: 41.582

2.  In situ cancer vaccination using lipidoid nanoparticles.

Authors:  Jinjin Chen; Min Qiu; Zhongfeng Ye; Thomas Nyalile; Yamin Li; Zachary Glass; Xuewei Zhao; Liu Yang; Jianzhu Chen; Qiaobing Xu
Journal:  Sci Adv       Date:  2021-05-05       Impact factor: 14.136

3.  Long-Term Programming of CD8 T Cell Immunity by Perinatal Exposure to Glucocorticoids.

Authors:  Jun Young Hong; Jaechul Lim; Fernando Carvalho; Jen Young Cho; Bharat Vaidyanathan; Shuang Yu; Charles Annicelli; W K Eddie Ip; Ruslan Medzhitov
Journal:  Cell       Date:  2020-03-05       Impact factor: 41.582

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.